Precipitation complexation method produces cannabidiol/β-cyclodextrin inclusion complex suitable for sublingual administration of cannabidiol

Journal of Pharmaceutical Sciences

Volumn 96, Issue 2, 2007, Pages 312-319

  Mannila, Janne ^a   Järvinen, Tomi ^a   Järvinen, Kristiina ^a   Jarho, Pekka ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Absorption; Buccal; Cyclodextrins; Preformulation; Transmucosal drug delivery

Indexed keywords

BETA CYCLODEXTRIN; CANNABIDIOL;

ANIMAL EXPERIMENT; ARTICLE; COMPLEX FORMATION; CONCENTRATION RESPONSE; DRUG ADSORPTION; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG SOLUBILITY; FEMALE; MALE; NONHUMAN; PRECIPITATION;

EID: 33847607136     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.20766     Document Type: Article

References (24)

1. Martin Del Valle EM. 2004. Cyclodextrins and their uses: A review. Process Biochem 39:1033-1046.
2. Loftsson T, Hreinsdottir D, Masson M. 2005. Evaluation of cyclodextrin solubilization of drugs. Int J Pharm 302(1-2):18-28.
3. Mannila J, Jarvinen T, Jarvinen K, Tarvainen M, Jarho P. 2005. Effects of RM-beta-CD on sublingual bioavailability of delta9-tetrahydrocannabinol in rabbits. Eur J Pharm Sci 26(1):71-77.
4. Yoo SD, Yoon BM, Lee HS, Lee KC. 1999. Increased bioavailability of clomipramine after sublingual administration in rats. J Pharm Sci 88(11):1119-1121.
5. Brown GA, Martini ER, Roberts BS, Vukovich MD, King DS. 2002. Acute hormonal response to sublingual androstenediol intake in young men. J Appl Physiol 92(1):142-146.
6. Loftsson T. 1998. Increasing the cyclodextrin complexation of drugs and drug bioavailability through addition of water-soluble polymers. Pharmazie 53(11):733-740.
7. Jarho P, Pate DW, Brenneisen R, Jarvinen T. 1998. Hydroxypropyl-beta- cyclodextrin and its combination with hydroxypropyl-methylcellulose increases aqueous solubility of delta9-tetrahydrocannabinol. Life Sci 63(26):PL381-384.
8. Loftsson T, Sigurdsson HH, Masson M, Schipper N. 2004. Preparation of solid drug/cyclodextrin complexes of acidic and basic drugs. Pharmazie 59(1):25-29.
9. Higuchi T, Connors KA. 1965. Phase-solubility techniques. In: Reilley CN, editor. Advances in analytical chemistry instrumentation. New York: Interscience publishers/John Wiley & Sons. pp 117-212.
10. Frömming K-H, Szejtli J. 1994. Cyclodextrins in pharmacy. Dordrecht: Kluwer Academic Publishers.
11. Zajicek J, Fox P, Sanders H, Wright D, Vickery J, Nunn A, Thompson A. 2003. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): Multicentre randomised placebo-controlled trial. Lancet 362(9395):1517-1526.
12. Wade DT, Robson P, House H, Makela P, Aram J. 2003. A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms. Clin Rehabil 17(1):21-29.
13. Lastres-Becker I, Molina-Holgado F, Ramos JA, Mechoulam R, Fernández-Ruiz J. 2005. Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's disease. Neurobiol Dis 19:96-107.
14. Ohlsson A, Lindgren JE, Andersson S, Agurell S, Gillespie H, Hollister LE. 1986. Single-dose kinetics of deuterium-labelled cannabidiol in man after smoking and intravenous administration. Biomed Environ Mass Spectrom 13(2):77-83.
15. Mannila J, Lehtonen M, Jarvinen T, Jarho P. 2004. Determination of delta9-tetrahydrocannabinol from rabbit plasma by gas chromatography-mass spectrometry using two ionization techniques. J Chromatogr B Analyt Technol Biomed Life Sci 810(2):283-290.
16. Kinnarinen T, Jarho P, Jarvinen K, Jarvinen T. 2003. Pulmonary deposition of a budesonide/gamma-cyclodextrin complex in vitro. J Control Release 90(2):197-205.
17. Liu FY, Kildsig DO, Mitra AK. 1990. Beta-cyclodextrin/steroid complexation: Effect of steroid structure on association equilibria. Pharm Res 7(8):869-873.
18. Nicolazzo JA, Reed BL, Finnin BC. 2005. Buccal penetration enhancers - How do they really work? J Control Release 105(1-2):1-15.
19. Kitano M, Maitani Y, Takayama K, Nagai T. 1998. Buccal absorption through golden hamster cheek pouch in vitro and in vivo of 17β-estradiol from hydrogels containing three types of absorption enhancers. Int J Pharm 174:19-28.
20. Mannila J, Jarvinen T, Jarvinen K, Tervonen J, Jarho P. 2006. Sublingual administration of delta9-tetrahydrocannabinol/beta-cyclodextrin complex increases the bioavailability of delta9-tetrahydrocannabinol in rabbits. Life Sci 78(17): 1911-1914.
21. Irie T, Uekama K. 1997. Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J Pharm Sci 86(2):147-162.
22. Rajewski RA, Stella VJ. 1996. Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery. J Pharm Sci 85(11):1142-1169.
23. Weatherell JA, Robinson C, Rathbone MJ. 1996. The flow of saliva and its influence on the movement, deposition and removal of drugs administered to the oral cavity. In: Rathbone MJ, editor. Oral mucosal drug delivery. Hamilton, New Zealand: Marcel Dekker, Inc.
24. GW Pharmaceuticals Ltd. 2005. Sativex Product Monograph 2005, (http://www.bayerhealth.com/display.cfm?Object_ID=272&Article_ID=122).